journal
MENU ▼
Read by QxMD icon Read
search

Journal of Breast Cancer

journal
https://www.readbyqxmd.com/read/28690660/a-case-of-breast-cancer-brain-metastasis-with-a-16-year-time-interval-without-evidence-of-cancer-recurrence
#1
Shoko Merrit Yamada, Yusuke Tomita, Soichiro Shibui, Takashi Kurokawa, Yasuhisa Baba
The median time of brain metastasis from the diagnosis of breast cancer is approximately 3 years. In this case report, a 69-year-old woman demonstrated cerebellar ataxia. Brain magnetic resonance imaging revealed enhanced lesions in bilateral cerebellar hemispheres. She had undergone surgery, radiation, and chemotherapy for uterine and breast cancer 24 years prior and 16 years prior, respectively. Although she had not received any anticancer treatment for 10 years, no recurrences were identified using whole body scans...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690659/chronic-myeloid-leukemia-with-a-complex-variant-ph-translocation-that-develops-in-breast-carcinoma-postchemotherapy-a-rare-but-treatable-entity
#2
Gargi Tikku, Monica Jain, Pragya Shukla
We report a case of chronic myeloid leukemia (CML) that developed after postoperative chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) for breast cancer. A 55-year-old woman was diagnosed with invasive ductal carcinoma which was treated with a modified radical mastectomy followed by six cycles of CAF chemotherapy. Nine years later, she developed CML and locoregional recurrence. Her breast recurrence showed strong estrogen receptor, weak progesterone receptor and strong human epidermal growth factor 2 (score 3+) expression...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690658/influence-of-the-angelina-jolie-announcement-and-insurance-reimbursement-on-practice-patterns-for-hereditary-breast-cancer
#3
Jihyoun Lee, Sungwon Kim, Eunyoung Kang, Suyeon Park, Zisun Kim, Min Hyuk Lee
Lack of awareness, the stigma of carrying a genetic mutation, and economic factors are barriers to acceptance of BRCA genetic testing or appropriate risk management. We aimed to investigate the influence of Angelina Jolie's announcement of her medical experience and also health insurance reimbursement for BRCA gene testing on practice patterns for hereditary breast and ovarian cancer (HBOC). A survey regarding changes in practice patterns for HBOC before and after the announcement was conducted online. The rate of BRCA gene testing was obtained from the National Health Insurance Review and Assessment Service database...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690657/epigenetic-silencing-of-mort-is-an-early-event-in-cancer-and-is-associated-with-luminal-receptor-positive-breast-tumor-subtypes
#4
Lukas Vrba, Bernard Walter Futscher
Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) to this process. This study evaluated the epigenetic and transcriptional state of MORT in two premalignant conditions-ductal carcinomas in situ and colon adenomas. Results show that MORT silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690656/imaging-surveillance-for-survivors-of-breast-cancer-correlation-between-cancer-characteristics-and-method-of-detection
#5
A Jung Chu, Jung Min Chang, Nariya Cho, Woo Kyung Moon
PURPOSE: The aim of our study was to investigate the characteristics of primary and recurrent breast cancers and the correlation between cancer subtypes and detection modes. METHODS: Between 2003 and 2013, 147 cases of recurrent breast cancer in 137 women (mean age, 45.30±10.78 years) were identified via an annual clinical examination using radiological studies among 6,169 patients with a breast cancer history (mean follow-up period, 13.26±1.78 years). Clinical, radiological, and pathological findings including immunohistochemistry findings of primary and recurrent cancers were reviewed...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690655/screening-uptake-differences-are-not-implicated-in-poorer-breast-cancer-outcomes-among-singaporean-malay-women
#6
Wong Ru Xin, Li-Lian Kwok, Wong Fuh Yong
PURPOSE: This study was undertaken to examine the impact of screening and race on breast cancer outcomes in Singapore. METHODS: An institutional database was reviewed, and invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS) data were analyzed separately. Overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS) were assessed. RESULTS: The study included 6,180 IDC and 1,031 DCIS patients. The median follow-up time was 4...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690654/the-usefulness-of-intraoperative-circumferential-frozen-section-analysis-of-lumpectomy-margins-in-breast-conserving-surgery
#7
SeungSang Ko, Yi Kyeong Chun, Sung Soo Kang, Min Hee Hur
PURPOSE: Intraoperative frozen-section analysis of the lumpect-omy margin during breast-conserving surgery (BCS) is an excellent method in obtaining a clear resection margin. This study aimed to investigate the usefulness of intraoperative circumferential frozen-section analysis (IOCFS) of lumpectomy margin during BCS for breast cancer, and to find factors that increase the conversion into mastectomy. METHODS: From 2007 to 2011, 509 patients with breast cancer underwent IOCFS during BCS...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690653/high-histologic-grade-and-high-ki-67-expression-predict-phenotypic-alterations-in-node-metastasis-in-primary-breast-cancers
#8
Pablo Mandó, Manglio Rizzo, Constanza Perez de la Puente, Mercedes Maino, Carolina Ponce, Maria Teresa Pombo, Mora Amat, Maria Victoria Costanzo, Adrian Nervo, Jorge Nadal, Veronica Fabiano, Jose Loza, Carlos Martin Loza, Federico Colo, Chacon Reinaldo
PURPOSE: Several studies have shown that estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) expression may vary during tumoral progression. We aimed to describe and compare ER, PR, and HER2 expressions in primary breast tumors and synchronic axillary nodal metastases, and evaluate phenotypic correlations between them. METHODS: Patients were identified prospectively through surgical procedures between September 2013 and July 2016...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690652/prognostic-impact-of-progesterone-receptor-status-in-chinese-estrogen-receptor-positive-invasive-breast-cancer-patients
#9
Nan Yao, Zhenchuan Song, Xinle Wang, Shan Yang, Heng Song
PURPOSE: Estrogen receptor (ER) and progesterone receptor (PR) have been used as indicators of endocrine system status since the mid-1970s in the clinical management of breast cancer. The predictive role of ER in endocrine therapy is undisputed, but the prognostic value of PR is still debated. The aim of this study was to investigate the clinical characteristics and prognosis of ER positive breast cancer with different PR expression levels. METHODS: A population cohort of 3,030 primary invasive ER positive breast cancer patients from a single cancer center underwent surgery and received adjuvant endocrine therapy from 2004 to 2010...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690651/mutations-of-the-epidermal-growth-factor-receptor-gene-in-triple-negative-breast-cancer
#10
Aeri Kim, Min Hye Jang, Soo Jung Lee, Young Kyung Bae
PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is low and varies with ethnicity. This study aimed to investigate the incidence of EGFR gene mutation in TNBC. METHODS: EGFR protein expression was evaluated by immunohistochemistry in tissue microarrays of 493 TNBC cases using four different primary antibodies, which included mutation-specific antibodies...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690650/cd49f-can-act-as-a-biomarker-for-local-or-distant-recurrence-in-breast-cancer
#11
Feng Ye, Xiaorong Zhong, Yan Qiu, Libo Yang, Bing Wei, Zhang Zhang, Hong Bu
PURPOSE: Metastasis and local recurrence are the primary causes of treatment failure and patient death in breast cancer. The aim of this study was to validate a metastasis- and local recurrenceassociated biomarker for prognostic evaluation and planning treatment strategies. METHODS: Formalin-fixed, paraffin-embedded tissues from a cohort of 312 patients (all stage II and III) were used. The prevalence of CD49f(+) cells in the patients' tumors was analyzed and correlated with clinical characteristics to determine its prognostic and clinical implications...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690649/overexpression-of-uridine-cytidine-kinase-2-correlates-with-breast-cancer-progression-and-poor-prognosis
#12
Guosong Shen, Pingya He, Yingying Mao, Peipei Li, Frank Luh, Guohui Ding, Xiyong Liu, Yun Yen
PURPOSE: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosynthesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer and may play a crucial role in activating antitumor prodrugs in human cancer cells. In the current study, we evaluated the potential prognostic value of UCK2 in breast cancer. METHODS: We searched public databases to explore associations between UCK2 gene expression and clinical parameters in patients with breast cancer...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28690648/recent-advances-in-the-neoadjuvant-treatment-of-breast-cancer
#13
REVIEW
Gábor Rubovszky, Zsolt Horváth
In the last few decades, neoadjuvant therapy for breast cancer has gained considerable therapeutic importance. Despite extensive clinical investigations, it has not yet been clarified whether neoadjuvant therapy would result in improved survival in comparison with the standard adjuvant setting in any subgroups of patients with breast cancer. Chemotherapy is especially effective in the treatment of endocrine insensitive tumors, and such ther-apeutic benefit can be assumed for patients with triple-negative, or hormone receptor-negative and human epidermal growth factor receptor 2 (HER2)-positive breast cancer...
June 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382106/erratum-validation-of-a-web-based-tool-to-predict-the-ipsilateral-breast-tumor-recurrence-ibtr-2-0-after-breast-conserving-therapy-for-korean-patients
#14
Seung Pil Jung, Sung Mo Hur, Se Kyung Lee, Sangmin Kim, Min-Young Choi, Soo Youn Bae, Jiyoung Kim, Min Kuk Kim, Won Ho Kil, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Seok Jin Nam, Jeoung Won Bae, Jeong Eon Lee
[This corrects the article on p. 97 in vol. 16, PMID: 23593089.].
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382105/erratum-magnetic-resonance-imaging-features-of-adenosis-in-the-breast
#15
Masoumeh Gity, Ali Arabkheradmand, Elham Taheri, Madjid Shakiba, Yassaman Khademi, Bijan Bijan, Mohammad Salehi Sadaghiani, Amir Hossein Jalali
[This corrects the article on p. 187 in vol. 18, PMID: 26155296.].
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382104/comment-on-histomorphological-factors-predicting-the-response-to-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer
#16
COMMENT
Kadri Altundag
No abstract text is available yet for this article.
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382103/comment-on-chemotherapy-induced-left-ventricular-dysfunction-in-patients-with-breast-cancer
#17
COMMENT
Kadri Altundag
No abstract text is available yet for this article.
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382102/bilateral-triple-negative-invasive-breast-cancer-with-a-brca2-mutation-and-glioblastoma-a-case-report-and-literature-review
#18
Ali Raufi, Mohamed Alsharedi, Yousef Khelfa, Maria Tirona
Breast cancer is the second leading cause of death among women in North America. Glioblastoma is the most common primary malignant central nervous system tumor in adults. The majority of hereditary breast cancers are associated with deleterious mutations in the BRCA1 and BRCA2 genes. Although few case reports have described the incidence of glioblastoma in patients previously diagnosed with breast cancer, any association between BRCA2 mutations and glioblastoma has not been demonstrated to date. Herein, we report a woman who is a carrier of a familial BRCA2 mutation, and was previously diagnosed with triple-negative breast cancer (TNBC) and subsequently with a second primary TNBC and glioblastoma...
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382101/brip1-fancj-mutation-analysis-in-a-family-with-history-of-male-and-female-breast-cancer-in-india
#19
Ananthapur Venkateshwari, David Wayne Clark, Pratibha Nallari, Cingeetham Vinod, Thangaraj Kumarasamy, Goverdhan Reddy, Akka Jyothy, Malladi Vijay Kumar, Raghuraman Ramaiyer, Komaraiah Palle
Male breast cancer (MBC) is a rare and poorly studied disease that is a growing global health problem. Interestingly, both the molecular basis of MBC and its histological profile are often quite distinct from the far more prevalent female breast cancer, emphasizing the need for increased focus on MBC. Here, we present a case report of an MBC patient from India with a strong familial history of breast cancer. This patient was normal for BRCA1/2 and many other common breast cancer-associated genes. However, upon further analysis, the individual was found to possess two mutations in the DNA helicase and tumor suppressor gene BRIP1, including a silent mutation at residue 879 as well as a P919S variant...
March 2017: Journal of Breast Cancer
https://www.readbyqxmd.com/read/28382100/patient-satisfaction-with-implant-based-breast-reconstruction-associated-with-implant-volume-and-mastectomy-specimen-weight-ratio
#20
Woo Yeol Baek, Il Hwan Byun, Young Seok Kim, Dae Hyun Lew, Joon Jeong, Tai Suk Roh
PURPOSE: Breast volume assessment is one of the most important steps during implant-based breast reconstruction because it is critical in selecting implant size. According to previous studies, there is a close relationship between the mastectomy specimen weight and resected breast volume. The aim of this study was to evaluate long-term patient satisfaction with implant-based breast reconstruction guided by the ratio of implant volume to mastectomy specimen weight. In doing so, we describe the ideal ratio for patient satisfaction...
March 2017: Journal of Breast Cancer
journal
journal
41722
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"